SynthesisOncoimmunology2020

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma.

Chaoqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.